InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Northpond Ventures GP, LLC. Officer active across 3 companies, notably Codex DNA, Inc.. In total, 7 disclosures have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €83.6m. History available since 22 June 2023. The latest transaction was filed on 22 June 2023 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations7 total
1,969,368 shares@ US$46.50100.0% of flowCommon StockSEC:0000899243-23-016413:0
2,831,520 sharesCommon StockSEC:0000899243-22-001631
2,831,520 sharesCommon StockSEC:0000899243-22-001631:0
2,603,075 sharesCommon StockSEC:0000899243-21-036646:0
2,603,075 sharesCommon StockSEC:0000899243-21-036646
9,375,380 sharesCommon StockSEC:0000899243-21-025745
9,375,380 sharesCommon StockSEC:0000899243-21-025745:0
7 of 7 declarations
About Northpond Ventures GP, LLC
Northpond Ventures GP, LLC is a director and insider for Codex DNA, Inc., DICE Therapeutics, Inc., and Vigil Neuroscience, Inc.
